COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants

Summary: COVID-19 vaccine efficacy is threatened by emerging SARS-CoV-2 variants of concern (VOC) with the capacity to evade protective neutralizing antibody responses. We recently developed clinical vaccine candidate COH04S1, a synthetic modified vaccinia Ankara vector (sMVA) co-expressing spike an...

Full description

Bibliographic Details
Main Authors: Felix Wussow, Mindy Kha, Katelyn Faircloth, Vu H. Nguyen, Angelina Iniguez, Joy Martinez, Yoonsuh Park, Jenny Nguyen, Swagata Kar, Hanne Andersen, Mark G. Lewis, Flavia Chiuppesi, Don J. Diamond
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222007283